Sublingual dexmedetomidine compositions and methods of use thereof

Details for Australian Patent Application No. 2010248776 (hide)

Owner Recro Pharma, Inc.

Inventors Henwood, Geraldine Anne; Mack, Randall Jerome; Sharr, Christopher Thomas; Koleng Jr., John Joseph

Agent FB Rice

Pub. Number AU-A-2010248776

PCT Pub. Number WO2010/132882

Priority 61/178,730 15.05.09 US

Filing date 17 May 2010

Wipo publication date 18 November 2010

International Classifications

A61K 9/107 (2006.01) Medicinal preparations characterised by special physical form - Emulsions

A61K 9/14 (2006.01) Medicinal preparations characterised by special physical form - Particulate form, e.g. powders

A61K 31/415 (2006.01) - 1,2-Diazoles

A61P 3/00 (2006.01) Drugs for disorders of the metabolism

A61P 17/02 (2006.01) Drugs for dermatological disorders

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

12 January 2012 PCT application entered the National Phase

  PCT publication WO2010/132882 Priority application(s): WO2010/132882

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010248782-Methods and compositions relating to fusions of ALK for diagnosing and treating cancer

2010248761-Vaccine immunotherapy